CANDEL THERAPEUTICS, INC.
CANDEL THERAPEUTICS, INC. is a Public Limited Company registered in United States under 000975193, and its current status with Massachusetts Secretary of the Commonwealth is active. The company was incorporated on 7 April 2008 and lists its registered address as NEEDHAM, United States. 5 shareholders are on record for CANDEL THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Massachusetts Secretary of the Commonwealth and was last updated on 18 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Shareholders of CANDEL THERAPEUTICS, INC.
Five shareholders are currently on record for CANDEL THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Acorn Capital Advisors, LLC , holding 6.4% — the largest recorded stake — followed by iShares Trust-iShares Russell 2000 ETF at 3.5%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data availability
The register reports 9 shareholders in total, though only the top 5 by holding are shown in this view.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Acorn Capital Advisors, LLC | 6.4% | Massachusetts Secretary of the Commonwealth | |
| iShares Trust-iShares Russell 2000 ETF | 3.5% | Massachusetts Secretary of the Commonwealth | |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 2.7% | Massachusetts Secretary of the Commonwealth | |
| Halter Ferguson Financial Inc. | 2.1% | Massachusetts Secretary of the Commonwealth | |
| iShares Trust-iShares Biotechnology ETF | 1% | Massachusetts Secretary of the Commonwealth |
Officers
27
Directors and officers of CANDEL THERAPEUTICS, INC.
The President, Ceo & Director of CANDEL THERAPEUTICS, INC. currently on record is Paul-peter Tak Focis, M.d., Ph.d.; 16 of the 27 officer records shown for CANDEL THERAPEUTICS, INC. are current appointments, filed with Massachusetts Secretary of the Commonwealth. The remaining 9 records shown (JOSEPH PAPA, DIEM NGUYEN and 7 others) are former appointments that have since been resigned. Management authority at CANDEL THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns CANDEL THERAPEUTICS, INC.?
Five shareholders are currently on record for CANDEL THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Acorn Capital Advisors, LLC , holding 6.4% — the largest recorded stake — followed by iShares Trust-iShares Russell 2000 ETF at 3.5%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is CANDEL THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for CANDEL THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does CANDEL THERAPEUTICS, INC. have on record?
5 shareholders are shown on record for CANDEL THERAPEUTICS, INC.. The register reports 9 in total; only the top 5 by holding are shown here.
What is CANDEL THERAPEUTICS, INC.'s company registration number?
CANDEL THERAPEUTICS, INC.'s registration number is 000975193, filed with Massachusetts Secretary of the Commonwealth in United States. Its current status on the register is active.
Is CANDEL THERAPEUTICS, INC. still an active company?
CANDEL THERAPEUTICS, INC.'s status on Massachusetts Secretary of the Commonwealth is listed as active.
When was CANDEL THERAPEUTICS, INC. incorporated?
CANDEL THERAPEUTICS, INC. was incorporated on 7 April 2008, according to Massachusetts Secretary of the Commonwealth.
What is CANDEL THERAPEUTICS, INC.'s registered address?
The registered address on file for CANDEL THERAPEUTICS, INC. is NEEDHAM, United States.
What legal structure is CANDEL THERAPEUTICS, INC. registered as?
CANDEL THERAPEUTICS, INC. is registered as a Public Limited Company in United States.
Who are the officers/directors of CANDEL THERAPEUTICS, INC.?
The President, Ceo & Director of CANDEL THERAPEUTICS, INC. currently on record is Paul-peter Tak Focis, M.d., Ph.d.; 16 of the 27 officer records shown for CANDEL THERAPEUTICS, INC. are current appointments, filed with Massachusetts Secretary of the Commonwealth. The remaining 9 records shown (JOSEPH PAPA, DIEM NGUYEN and 7 others) are former appointments that have since been resigned. Management authority at CANDEL THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to CANDEL THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Massachusetts Secretary of the Commonwealth. Zavia's monitoring API can track changes to CANDEL THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access CANDEL THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like CANDEL THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Massachusetts Secretary of the Commonwealth and was last synced on 18 September 2026.